+116%

est. 2Y upside i

HealthcareClimate TechSeries D+

maximizing biomass on low quality land

Rank

#310

Sector

Biotechnology, Climate Tech

Est. Liquidity

~4Y

Data Quality

Data: Medium

Living Carbon's equity offers asymmetric upside potential but with severe preference overhang suppressing current common value.

Last updated: July 19, 2026

Bull (30%)+200%

With IPO window and category leadership, multiple expands to 10x revenue, yielding $177.7M exit. After preference and 20% dilution, common stock value reaches $102.96M, upside capped at 200% per stage constraints.

Base (50%)+144%

Exit multiple converges to 6x revenue, exit value $106.62M. After preference and dilution, common stock value $46.1M, representing 144% upside.

Bear (20%)-82%

Multiple compresses to 3x revenue due to regulatory challenges, exit $53.31M. After preference, common recovers $4.31M; after 20% dilution, $3.45M, a -82% return.

Est. time to liquidity~4.0 years

Preference Stack Risk

severe

Funding Intensity

43400%

Total preferred liquidation preference of $49M exceeds current $18.9M valuation, common stock is deeply underwater.

Dilution Risk

high

Expected capital raise within 24 months will dilute existing common by approximately 20%.

Secondary Liquidity

none

No secondary market activity reported; liquidity expected only at exit.

Questions to Ask at the Interview

Strategic questions based on Living Carbon's data — designed to show you've done your homework.

  • 1

    How does the genetic engineering of trees differ from traditional biotech, and what are the key scientific risks?

  • 2

    Given the $500M Octopus deal, what is the expected revenue recognition timeline and gross margin profile?

  • 3

    How does the current management plan to navigate regulatory approvals for genetically modified trees across different jurisdictions?

Community

Valuation Sentiment

Our model estimates +116% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.